Project Grant HT94252310964
Award Date 9/30/23
Completion Date 9/29/26
Dollars Obligated $830K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency has awarded a $1,255,505 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The grant, which has a performance period of July 1, 2024 to June 30, 2027, is for the development of a unique small molecule for the treatment of triple-negative breast cancer. As a leading academic medical center, Penn State has...
- The University of Pennsylvania, through its Clinical Practices division, was awarded a $812,500 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting UGCG in the Melanoma Tumor Microenvironment." This 3-year research project, which commenced on September 1, 2024, aims to investigate innovative approaches to treating melanoma, a serious form of skin cancer, with a focus on modulating the tumor...
- The Pennsylvania State University will receive $979,599 from the Defense Health Agency through September 1, 2023 to August 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). The project aims to develop a novel approach to target metabolic vulnerabilities in metastatic lung cancer. Through this funding, Penn State researchers will investigate medical solutions for cancer on the battlefield and transform healthcare for service members and the public...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $765,000 Project Grant to Washington State University to support a 3-year research project titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". The research aims to develop new prevention strategies for melanoma by investigating the use of mouse models with humanized telomeres. The grant was awarded on September 30, 2023...
- The U.S. Defense Health Agency awarded a $384,063 Project Grant to The Pennsylvania State University (Penn State) under the Military Medical Research and Development program (CFDA 12.420). The grant provides funding from February 1, 2025 through January 31, 2027 for a project titled "Direct Genetic Modification of Plasmodium Sporozoites by mRNA/Lipid Nanoparticles". The project aims to conduct advanced biomedical research into innovative medical solutions to address critical health...
- The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...
- The University of Pittsburgh was awarded a $1,144,800 Project Grant by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Overcoming Immunotherapy Resistance in Acral Melanoma." The three-year project, starting on September 1, 2025, and completing on August 31, 2028, aims to investigate innovative medical solutions to address this critical health challenge relevant to military personnel and the broader...
- This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
- This $726,989 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Pittsburgh on immunotherapeutic targeting of SLC39A9 in CDKN2A-low melanoma. The research aims to develop novel diagnostic tools, therapeutic interventions, and clinical practice guidelines to address critical health challenges relevant to military personnel. The project will span 3 years, from September 2025...
- The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...